-
The Joint Commission has created some Q&A clarification of its standards regarding tissue handling and transplantation in light of some highly publicized incidents of inappropriate practices.
-
Rosuvastatin and atorvastatin at their maximal doses, favorably change HDL subpopulation levels, but rosuvastatin is significantly more potent than atorvastatin for this purpose
-
Rosuvastatin plus ezetimibe may improve the management of high-risk patients by increasing the number that reach goal LDL cholesterol levels.
-
Women harbor less atherosclerotic plaque within their coronary arteries, despite the greater prevalence of atherogenic risk factors.
-
Revisions of BMI cut-points to define obesity in ethnic minorities may be warranted.
-
In children affected by Brugada syndrome there is no male predominance, a very strong linkage to febrile episodes and a high incidence of SCN5A mutations.
-
-
-
EPA treatment added to statins reduces nonfatal CHD events in hypercholesterolaemic Japanese patients.
-
Appropriate and seemingly inappropriate use of anticoagulation is occurring among patients with atrial fibrillation.
